Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Manlio Loconte

Anatomic Pathology & Clinical Pathology Boston, MA Medical Doctor

NPI 1114984820 CMS profile 1248937

800 Washington Street Box 1013, Boston, MA 02111

Open in the dashboard

General payments

$112,233

36 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Manlio Loconte of Boston, MA is reported in the CMS Open Payments database as having received $112,233 across 36 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $42,862 13
2024 General $41,600 12
2023 General $27,733 8
2020 General $15 1
2019 General $23 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Manlio Loconte
  • Anatomic Pathology & Clinical Pathology median
  • Middle half of Anatomic Pathology & Clinical Pathology
  • National median

In program year 2025, general payments to Manlio Loconte were reported at $42,862. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.

Show as a table
Year Manlio Loconte Anatomic Pathology & Clinical Pathology median Middle half National median
2019 $23 $65 $22–$150 $163
2020 $15 $44 $19–$144 $114
2021 $0 $42 $19–$142 $132
2022 $0 $54 $20–$140 $149
2023 $27,733 $60 $23–$157 $160
2024 $41,600 $51 $23–$145 $164
2025 $42,862 $51 $24–$149 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $112,195 33 payments
  2. Orexo US, Inc. $38 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $112,133 32 payments
  2. Travel and Lodging $62 1 payment
  3. Food and Beverage $38 3 payments
Products named General payments · program years 2019–2025
  1. Zubsolv $38 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

250

Median for Pathology: 39

Drug cost

$38,210

Median for Pathology: $2,261

Branded share of claims

93.2%

Median for Pathology: 4.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Suboxone Buprenorphine Hcl/Naloxone Hcl Brand 68 $23,598
Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl Brand 165 $14,453
Buprenorphine Hcl Generic 17 $159

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 205 Part D prescribers listed as Pathology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$33,826

Medicare's payments for the services billed

Medicare patients

13

Average age 56

Services billed

427

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Atrial fibrillation 0%
Chronic kidney disease 0%
Cancer 0%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

36 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anatomic Pathology & Clinical Pathology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record